UNSPSC 85815620: Introduction of other thrombolytic into central vein, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other thrombolytic into central vein, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E04017

UNSPSC 85815620 (Introduction of other thrombolytic into central vein, open approach) is a Commodity code with no meaningful recent state and local procurement activity that aligns with its clinical taxonomy. The code nominally describes a specific medical procedure—intravenous thrombolytic administration—but the recent opportunities tagged under this code span unrelated healthcare services including virtual urgent care, occupational health exams, cancer screening, medical directorships, EMS revenue billing, behavioral health treatment, opioid use disorder services, youth crisis stabilization, and employee wellness platforms. This mismatch between the UNSPSC label and actual solicitation scope signals that the code does not capture coherent procurement demand in state and local markets and should not be relied upon for business development targeting.

The source records no state or local government solicitations for thrombolytic administration or related acute procedural clinical services under this code. The opportunities posted against it reflect healthcare system administration, occupational health compliance, and behavioral health program management—categories orthogonal to emergency thrombectomy or thrombolytic therapy delivery. Buyers across California, Georgia, Nevada, Colorado, Florida, Texas, Kansas, and other jurisdictions are investing in telemedicine platforms, medical directorships, cancer registries, occupational screening, and integrated behavioral health services, but none of these solicitations target pharmaceutical thrombolytic delivery or the clinical protocols that would accompany such intervention. When procurement codes misalign this dramatically with actual work being bought, the code itself is not actionable for vendor pursuit.